© 2008 The Medicines Company
Acute Care Hospital Products
NASDAQ: MDCO
Acute Care Hospital Products
NASDAQ: MDCO
The Medicines Company respects your privacy and recognizes the need for appropriate protection and management of any personally identifiable information you may share with us (the phrase “personally identifiable information” or “personal information” means any information by which you can be identified, such as your name, address, telephone number, etc.). The purpose of this Privacy Policy is to inform you how we may use personally identifiable information or personal information collected from you when you visit our Web site and the choices you have regarding our use of, and your ability to review and correct, the information collected.
Collection of Data
There may be times when we ask you to provide certain personal information about yourself, such as your name, address, telephone number, E-mail address, etc. Whether or not to provide such information is completely your own choice; we collect only the personal information that you provide to us. If you choose not to provide the information we request, you may be unable to access certain services, offers, and content on our Web site.
To enable us to provide customized and personalized services, we may use a passive tracking mechanism referred to as “cookies.” A cookie is a small amount of data that is sent to your browser from a Web server and stored on your computer. Cookies, by themselves, do not tell us any personally identifiable information about you. However, if you choose to furnish this Web site with personally identifiable information (such as your E-mail address), that information could be linked to the data stored in the cookie. We reserve the right to change our use of cookies and our practices regarding linkage to personally identifiable information without prior notification.
Use of Data
We use the information we automatically receive from your Web browser to see which pages you visit within our Web site. We can then develop statistics that are helpful to understanding how our Web site is used by our visitors. This statistical data is interpreted by us in our continuing effort to present Web site content that visitors are seeking in the format they find most helpful.
When we receive personally identifiable information, we may use it for reasonable business purposes, such as contacting you, via E-mail or regular mail, to provide you with information we believe may be of interest.
We will not sell, share, or otherwise distribute your personally identifiable information to third parties except as provided herein. Specifically, personally identifiable information may occasionally be transferred to third parties who act on our behalf, or in connection with our business, for further processing in accordance with the purposes for which the data was originally collected. Where disclosure of personally identifiable information to a third party is likely or necessary, further explanation may be provided, where appropriate, at such collection points as to the intended use of the data. We will require that such third parties protect the information and, where appropriate, we will contractually require them to process data transferred only for the purposes expressly authorized by us.
Because of the nature of the Internet, we may transmit the information to another country, while still maintaining the information in our system, for purposes other than direct marketing, such as for storage, or because of where our servers are located. We may also use the information to investigate security breaches or cooperate with authorities pursuant to a legal matter. We may remove the personally identifiable information and use the other information for historical, statistical, or scientific purposes. Our Web site contains links to other Web sites. Be aware that we are not responsible for the privacy practices of other Web sites.
Consent
Use of this Web site constitutes consent to data collection and use as described in this Policy.
User Responsibilities
It is important for all users to take precautionary steps to protect their personal and health-related information. Users should monitor and control access to their computer.
Children
This Web site is not intended or designed to attract children under the age of 13. We do not collect personally identifiable data from any person we know to be under the age of 13.
Updates
The Medicines Company reserves the right to change, modify, add or remove sections of this Policy, in part or in whole. Any changes to this Policy will be updated on this page. This Policy was last updated on August 1, 2008.
Contact Information
If you have any questions or concerns, please do not hesitate to contact The Medicines Company at 800.377.5768 or investor.relations@themedco.com.
Cleviprex is intended for intravenous use. Titrate drug depending on the response of the individual patient to achieve the desired blood pressure reduction. Monitor blood pressure and heart rate continually during infusion, and then until vital signs are stable. Patients who receive prolonged Cleviprex infusions and are not transitioned to other antihypertensive therapies should be monitored for the possibility of rebound hypertension for at least 8 hours after the infusion is stopped.
Cleviprex is contraindicated in patients with allergies to soybeans, soy products, eggs, or egg products; defective lipid metabolism such as pathologic hyperlipemia, lipoid nephrosis, or acute pancreatitis if it is accompanied by hyperlipidemia; and in patients with severe aortic stenosis.
Hypotension and reflex tachycardia are potential consequences of rapid upward titration of Cleviprex. Dihydropyridine calcium channel blockers can produce negative inotropic effects and exacerbate heart failure. Monitor heart failure patients carefully. Cleviprex gives no protection against the effects of abrupt beta-blocker withdrawal.
Most common adverse reactions (> 2%) are headache, nausea, and vomiting.
Cleviprex should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Maintain aseptic technique while handling Cleviprex. Cleviprex contains phospholipids and can support microbial growth. Do not use if contamination is suspected. Once the stopper is punctured, use and discard within 4 hours.
Please see full Prescribing Information.